Form SC TO-C Eaton Vance Senior Float Filed by: Eaton Vance Senior Floating-Rate Trust
As filed with the Securities and Exchange Commission on April 17, 2026
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR
13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
Eaton Vance Senior Floating-Rate Trust
(Name of Subject Company (Issuer))
Eaton Vance Senior Floating-Rate Trust
(Name of Filing Person (Issuer))
Auction Preferred Shares Series A, B, C and D, Par Value $0.01 Per Share
(Title of Class of Securities)
Series A – 27828Q204
Series B – 27828Q303
Series C – 27828Q402
Series D – 27828Q501
(CUSIP Number of Class of Securities)
Deidre E. Walsh
Eaton Vance Management
One Post Office Square
Boston, Massachusetts
(617) 672-8305
(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing persons)
| ☒ | Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
Check the appropriate boxes below to designate any transactions to which the statement relates:
| ☐ | third party tender offer subject to Rule 14d-1. |
| ☒ | issuer tender offer subject to Rule 13e-4. |
| ☐ | going-private transaction subject to Rule 13e-3. |
| ☐ | amendment to Schedule 13D under Rule 13d-2. |
Check the following box if the filing is a final amendment reporting the results of the tender offer. ☐
If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:
| ☐ | Rule 13e-4(i) (Cross-Border Issuer Tender Offer) |
| ☐ | Rule 14d-1(d) (Cross-Border Third-Party Tender Offer) |
Items 1-11.
Not Applicable.
Item 12. Exhibits.
| Exhibit No. | Document |
| 99.1(a) | Press release issued by the Issuer dated April 17, 2026 |
Item 13.
Not Applicable.
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Energy Fuels Expects to Achieve Full-Year Uranium Production Guidance by Mid-Year
- Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease
- Flashmixer Becomes the First Bitcoin Mixer Built for the Age of AI Agents
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share